Piper Sandler Reiterates Overweight Rating on Pacira Pharmaceuticals (PCRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| PACIRA (NASDAQ: PCRX) | Delayed: 36.31 -0.08 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.39 | 52 Week High | $80.25 | |||
| Open | $36.33 | 52 Week Low | $30.25 | |||
| Day High | $36.36 | P/E | N/A | |||
| Day Low | $36.31 | EPS | $-2.08 | |||
| Volume | 4,690,064 | |||||
